Contract with Customer, Asset, Net, Current - Not Material

No definition available.

Name:	revv_ContractWithCustomerAssetNetCurrentNotMaterial
Namespace Prefix:	revv_
Data Type:	xbrli:stringItemType
Balance Type:	na
Period Type:	duration

- Definition

Customer Deposits Received in Advance of Transfer of Control

+ References

No definition available.

+ Details

Name:	revv_CustomerDepositsReceivedInAdvanceOfTransferOfControl
Namespace Prefix:	revv_
Data Type:	xbrli:monetaryItemType
Balance Type:	credit
Period Type:	instant

- Definition

Remaining Performance Obligations

+ References

No definition available.

+ Details

Name:	revv_RemainingPerformanceObligations
Namespace Prefix:	revv_
Data Type:	xbrli:stringItemType
Balance Type:	na
Period Type:	duration

- Definition

Unbilled Receivables

+ References

No definition available.

+ Details

Name:	revv_UnbilledReceivables
Namespace Prefix:	revv_
Data Type:	xbrli:monetaryItemType
Balance Type:	debit
Period Type:	instant

- Definition

Unbilled Receivables, noncurrent

+ References

No definition available.

+ Details

Name:	revv_UnbilledReceivablesNoncurrent
Namespace Prefix:	revv_
Data Type:	xbrli:monetaryItemType
Balance Type:	debit
Period Type:	instant

- References

No definition available.

+ Details

Name:	us-gaap_ContractWithCustomerAssetAndLiabilityAbstract
Namespace Prefix:	us-gaap_
Data Type:	xbrli:stringItemType
Balance Type:	na
Period Type:	duration

- Definition

Amount of deferred income and obligation to transfer product and service to customer for which consideration has been received or is receivable.

+ References

Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef
-Topic 210
-SubTopic 10
-Name Accounting Standards Codification
-Section S99
-Paragraph 1
-Subparagraph (SX 210.5-02(26)(c))
-Publisher FASB
-URI https://asc.fasb.org/1943274/2147480566/210-10-S99-1

+ Details

Name:	us-gaap_DeferredRevenue
Namespace Prefix:	us-gaap_
Data Type:	xbrli:monetaryItemType
Balance Type:	credit
Period Type:	instant

- Definition

Amount of deferred income and obligation to transfer product and service to customer for which consideration has been received or is receivable, classified as current.

+ References

Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef
-Topic 210
-SubTopic 10
-Name Accounting Standards Codification
-Section S99
-Paragraph 1
-Subparagraph (SX 210.5-02(20))
-Publisher FASB
-URI https://asc.fasb.org/1943274/2147480566/210-10-S99-1

+ Details

Name:	us-gaap_DeferredRevenueCurrent
Namespace Prefix:	us-gaap_
Data Type:	xbrli:monetaryItemType
Balance Type:	credit
Period Type:	instant

- Definition

Amount of deferred income and obligation to transfer product and service to customer for which consideration has been received or is receivable, classified as noncurrent.

+ References

+ Details

Name:	us-gaap_DeferredRevenueNoncurrent
Namespace Prefix:	us-gaap_
Data Type:	xbrli:monetaryItemType
Balance Type:	credit
Period Type:	instant

- Definition

Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.

+ References

Reference 1: http://www.xbrl.org/2003/role/disclosureRef
-Topic 606
-SubTopic 10
-Name Accounting Standards Codification
-Section 50
-Paragraph 7
-Publisher FASB
-URI https://asc.fasb.org/1943274/2147479806/606-10-50-7

Reference 2: http://www.xbrl.org/2003/role/disclosureRef
-Topic 606
-SubTopic 10
-Name Accounting Standards Codification
-Section 50
-Paragraph 5
-Publisher FASB
-URI https://asc.fasb.org/1943274/2147479806/606-10-50-5

Reference 3: http://www.xbrl.org/2003/role/exampleRef
-Topic 606
-SubTopic 10
-Name Accounting Standards Codification
-Section 55
-Paragraph 91
-Subparagraph (a)
-Publisher FASB
-URI https://asc.fasb.org/1943274/2147479777/606-10-55-91

Reference 4: http://www.xbrl.org/2003/role/exampleRef
-Topic 606
-SubTopic 10
-Name Accounting Standards Codification
-Section 55
-Paragraph 91
-Subparagraph (b)
-Publisher FASB
-URI https://asc.fasb.org/1943274/2147479777/606-10-55-91

Reference 5: http://www.xbrl.org/2003/role/exampleRef
-Topic 606
-SubTopic 10
-Name Accounting Standards Codification
-Section 55
-Paragraph 91
-Subparagraph (c)
-Publisher FASB
-URI https://asc.fasb.org/1943274/2147479777/606-10-55-91

Reference 6: http://www.xbrl.org/2003/role/exampleRef
-Topic 606
-SubTopic 10
-Name Accounting Standards Codification
-Section 55
-Paragraph 91
-Subparagraph (d)
-Publisher FASB
-URI https://asc.fasb.org/1943274/2147479777/606-10-55-91

Reference 7: http://www.xbrl.org/2003/role/exampleRef
-Topic 606
-SubTopic 10
-Name Accounting Standards Codification
-Section 55
-Paragraph 91
-Subparagraph (e)
-Publisher FASB
-URI https://asc.fasb.org/1943274/2147479777/606-10-55-91

Reference 8: http://www.xbrl.org/2003/role/exampleRef
-Topic 606
-SubTopic 10
-Name Accounting Standards Codification
-Section 55
-Paragraph 91
-Subparagraph (f)
-Publisher FASB
-URI https://asc.fasb.org/1943274/2147479777/606-10-55-91

Reference 9: http://www.xbrl.org/2003/role/exampleRef
-Topic 606
-SubTopic 10
-Name Accounting Standards Codification
-Section 55
-Paragraph 91
-Subparagraph (g)
-Publisher FASB
-URI https://asc.fasb.org/1943274/2147479777/606-10-55-91

+ Details

Name:	us-gaap_DisaggregationOfRevenueLineItems
Namespace Prefix:	us-gaap_
Data Type:	xbrli:stringItemType
Balance Type:	na
Period Type:	duration

- Definition

Amount, excluding tax collected from customer, of revenue from satisfaction of performance obligation by transferring promised good or service to customer. Tax collected from customer is tax assessed by governmental authority that is both imposed on and concurrent with specific revenue-producing transaction, including, but not limited to, sales, use, value added and excise.

+ References

Reference 1: http://www.xbrl.org/2003/role/disclosureRef
-Topic 280
-SubTopic 10
-Name Accounting Standards Codification
-Section 50
-Paragraph 40
-Publisher FASB
-URI https://asc.fasb.org/1943274/2147482810/280-10-50-40

Reference 2: http://www.xbrl.org/2003/role/disclosureRef
-Topic 280
-SubTopic 10
-Name Accounting Standards Codification
-Section 50
-Paragraph 42
-Publisher FASB
-URI https://asc.fasb.org/1943274/2147482810/280-10-50-42

Reference 3: http://www.xbrl.org/2003/role/disclosureRef
-Topic 280
-SubTopic 10
-Name Accounting Standards Codification
-Section 50
-Paragraph 41
-Subparagraph (a)
-Publisher FASB
-URI https://asc.fasb.org/1943274/2147482810/280-10-50-41

Reference 4: http://www.xbrl.org/2003/role/disclosureRef
-Topic 280
-SubTopic 10
-Name Accounting Standards Codification
-Section 50
-Paragraph 32
-Subparagraph (ee)
-Publisher FASB
-URI https://asc.fasb.org/1943274/2147482810/280-10-50-32

Reference 5: http://www.xbrl.org/2003/role/disclosureRef
-Topic 280
-SubTopic 10
-Name Accounting Standards Codification
-Section 50
-Paragraph 30
-Subparagraph (a)
-Publisher FASB
-URI https://asc.fasb.org/1943274/2147482810/280-10-50-30

Reference 6: http://www.xbrl.org/2003/role/disclosureRef
-Topic 280
-SubTopic 10
-Name Accounting Standards Codification
-Section 50
-Paragraph 22
-Subparagraph (b)
-Publisher FASB
-URI https://asc.fasb.org/1943274/2147482810/280-10-50-22

Reference 7: http://www.xbrl.org/2003/role/disclosureRef
-Topic 280
-SubTopic 10
-Name Accounting Standards Codification
-Section 50
-Paragraph 22
-Subparagraph (a)
-Publisher FASB
-URI https://asc.fasb.org/1943274/2147482810/280-10-50-22

Reference 8: http://www.xbrl.org/2003/role/exampleRef
-Topic 220
-SubTopic 40
-Name Accounting Standards Codification
-Section 55
-Paragraph 4
-Publisher FASB
-URI https://asc.fasb.org/1943274/2147476153/220-40-55-4

Reference 9: http://www.xbrl.org/2003/role/exampleRef
-Topic 220
-SubTopic 40
-Name Accounting Standards Codification
-Section 55
-Paragraph 14
-Publisher FASB
-URI https://asc.fasb.org/1943274/2147476153/220-40-55-14

Reference 10: http://www.xbrl.org/2003/role/disclosureRef
-Topic 606
-SubTopic 10
-Name Accounting Standards Codification
-Section 50
-Paragraph 7
-Publisher FASB
-URI https://asc.fasb.org/1943274/2147479806/606-10-50-7

Reference 11: http://www.xbrl.org/2003/role/disclosureRef
-Topic 270
-SubTopic 10
-Name Accounting Standards Codification
-Section 50
-Paragraph 1
-Subparagraph (i)
-Publisher FASB
-URI https://asc.fasb.org/1943274/2147482964/270-10-50-1

Reference 12: http://www.xbrl.org/2003/role/disclosureRef
-Topic 924
-SubTopic 10
-Name Accounting Standards Codification
-Section S99
-Paragraph 1
-Subparagraph (SAB Topic 11.L)
-Publisher FASB
-URI https://asc.fasb.org/1943274/2147479941/924-10-S99-1

Reference 13: http://www.xbrl.org/2003/role/disclosureRef
-Topic 606
-SubTopic 10
-Name Accounting Standards Codification
-Section 50
-Paragraph 5
-Publisher FASB
-URI https://asc.fasb.org/1943274/2147479806/606-10-50-5

Reference 14: http://www.xbrl.org/2003/role/disclosureRef
-Topic 606
-SubTopic 10
-Name Accounting Standards Codification
-Section 50
-Paragraph 4
-Subparagraph (a)
-Publisher FASB
-URI https://asc.fasb.org/1943274/2147479806/606-10-50-4

+ Details

Name:	us-gaap_RevenueFromContractWithCustomerExcludingAssessedTax
Namespace Prefix:	us-gaap_
Data Type:	xbrli:monetaryItemType
Balance Type:	credit
Period Type:	duration

- Definition

Amount received for services rendered and products shipped, but not yet billed, for non-contractual agreements due within one year or the normal operating cycle, if longer.

+ References

No definition available.

+ Details

Name:	us-gaap_UnbilledReceivablesCurrent
Namespace Prefix:	us-gaap_
Data Type:	xbrli:monetaryItemType
Balance Type:	debit
Period Type:	instant

- Details

Name:	srt_StatementGeographicalAxis=srt_AmericasMember
Namespace Prefix:
Data Type:	na
Balance Type:
Period Type:

- Details

Name:	srt_StatementGeographicalAxis=srt_EuropeMember
Namespace Prefix:
Data Type:	na
Balance Type:
Period Type:

- Details

Name:	srt_StatementGeographicalAxis=srt_AsiaMember
Namespace Prefix:
Data Type:	na
Balance Type:
Period Type:

- Details

Name:	us-gaap_StatementBusinessSegmentsAxis=revv_DiagnosticsMember
Namespace Prefix:
Data Type:	na
Balance Type:
Period Type:

- Details

Name:	us-gaap_StatementBusinessSegmentsAxis=revv_LifeSciencesMember
Namespace Prefix:
Data Type:	na
Balance Type:
Period Type:

- Details

Name:	revv_MajorGoodsserviceLinesAxis=revv_LifeSciencesSolutionsMember
Namespace Prefix:
Data Type:	na
Balance Type:
Period Type:

- Details

Name:	revv_MajorGoodsserviceLinesAxis=revv_SoftwareMember
Namespace Prefix:
Data Type:	na
Balance Type:
Period Type:

- Details

Name:	revv_MajorGoodsserviceLinesAxis=revv_ReproductiveHealthMember
Namespace Prefix:
Data Type:	na
Balance Type:
Period Type:

- Details

Name:	revv_MajorGoodsserviceLinesAxis=revv_AppliedGenomicsMember
Namespace Prefix:
Data Type:	na
Balance Type:
Period Type:

- Details

Name:	revv_MajorGoodsserviceLinesAxis=revv_ImmunodiagnosticsMember
Namespace Prefix:
Data Type:	na
Balance Type:
Period Type:

Revenue (Details) - USD ($) $ in Thousands	3 Months Ended
Revenue (Details) - USD ($) $ in Thousands	Apr. 05, 2026	Mar. 30, 2025	Dec. 28, 2025
Disaggregation of Revenue [Line Items]
Segment revenue	$ 711,118	$ 664,762
Unbilled Receivables	106,700		$ 105,600
Unbilled Receivables, Current	74,400		72,400
Unbilled Receivables, noncurrent	32,300		33,200
Deferred Revenue	238,500		224,800
Deferred Revenue, Current	171,700		159,300
Deferred Revenue, Noncurrent	66,800		65,500
Customer Deposits Received in Advance of Transfer of Control	$ 20,300		$ 19,300
Remaining Performance Obligations	Transaction price allocated to the remaining performance obligationsThe Company applies the practical expedient and does not disclose information about remaining performance obligations that have original expected durations of one year or less. The estimated revenue expected to be recognized in the future related to performance obligations that are unsatisfied (or partially unsatisfied) at the end of the period are not material to the Company. The remaining performance obligations primarily include noncancelable purchase orders, noncancelable software subscriptions and cloud service contracts and long-term prepaid storage contracts.
Contract with Customer, Asset and Liability [Abstract]
Contract with Customer, Asset, Net, Current - Not Material	The Company had no material contract assets as of April 5, 2026 and December 28, 2025.
Americas [Member]
Disaggregation of Revenue [Line Items]
Segment revenue	$ 315,992	304,629
Europe [Member]
Disaggregation of Revenue [Line Items]
Segment revenue	223,046	181,792
Asia [Member]
Disaggregation of Revenue [Line Items]
Segment revenue	172,080	178,341
Diagnostics [Member]
Disaggregation of Revenue [Line Items]
Segment revenue	349,273	324,367
Diagnostics [Member] \| Americas [Member]
Disaggregation of Revenue [Line Items]
Segment revenue	130,441	120,350
Diagnostics [Member] \| Europe [Member]
Disaggregation of Revenue [Line Items]
Segment revenue	131,351	105,770
Diagnostics [Member] \| Asia [Member]
Disaggregation of Revenue [Line Items]
Segment revenue	87,481	98,247
Life Sciences [Member]
Disaggregation of Revenue [Line Items]
Segment revenue	361,845	340,395
Life Sciences [Member] \| Americas [Member]
Disaggregation of Revenue [Line Items]
Segment revenue	185,551	184,279
Life Sciences [Member] \| Europe [Member]
Disaggregation of Revenue [Line Items]
Segment revenue	91,695	76,022
Life Sciences [Member] \| Asia [Member]
Disaggregation of Revenue [Line Items]
Segment revenue	84,599	80,094
Life Sciences Solutions [Member]
Disaggregation of Revenue [Line Items]
Segment revenue	299,996	286,453
Life Sciences Solutions [Member] \| Diagnostics [Member]
Disaggregation of Revenue [Line Items]
Segment revenue	0	0
Life Sciences Solutions [Member] \| Life Sciences [Member]
Disaggregation of Revenue [Line Items]
Segment revenue	299,996	286,453
Software [Member]
Disaggregation of Revenue [Line Items]
Segment revenue	61,849	53,942
Software [Member] \| Diagnostics [Member]
Disaggregation of Revenue [Line Items]
Segment revenue	0	0
Software [Member] \| Life Sciences [Member]
Disaggregation of Revenue [Line Items]
Segment revenue	61,849	53,942
Reproductive health [Member]
Disaggregation of Revenue [Line Items]
Segment revenue	147,442	126,805
Reproductive health [Member] \| Diagnostics [Member]
Disaggregation of Revenue [Line Items]
Segment revenue	147,442	126,805
Reproductive health [Member] \| Life Sciences [Member]
Disaggregation of Revenue [Line Items]
Segment revenue	0	0
Applied genomics [Member]
Disaggregation of Revenue [Line Items]
Segment revenue		664,762
Immunodiagnostics [Member]
Disaggregation of Revenue [Line Items]
Segment revenue	201,831	197,562
Immunodiagnostics [Member] \| Diagnostics [Member]
Disaggregation of Revenue [Line Items]
Segment revenue	201,831	197,562
Immunodiagnostics [Member] \| Life Sciences [Member]
Disaggregation of Revenue [Line Items]
Segment revenue	$ 0	$ 0